Form 8-K - Current report:
SEC Accession No. 0001144204-19-037255
Filing Date
2019-08-01
Accepted
2019-08-01 17:15:27
Documents
3
Period of Report
2019-08-01
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tv526497_8k.htm 8-K 21716
2 EXHIBIT 99.1 tv526497_ex99-1.htm EX-99.1 6930
3 GRAPHIC image_001.jpg GRAPHIC 3682
  Complete submission text file 0001144204-19-037255.txt   35216
Mailing Address GLENPOINTE CENTRE EAST, 3RD FLOOR 300 FRANK W. BURR BLVD., SUITE 21 TEANECK NJ 07666
Business Address GLENPOINTE CENTRE EAST, 3RD FLOOR 300 FRANK W. BURR BLVD., SUITE 21 TEANECK NJ 07666 201-329-7300
PHIBRO ANIMAL HEALTH CORP (Filer) CIK: 0001069899 (see all company filings)

EIN.: 131840497 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-36410 | Film No.: 19993595
SIC: 2834 Pharmaceutical Preparations